NEW YORK, March 14, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Adeptus Health, Inc. ("Adeptus Health" or the "Company") (NYSE: ADPT) (ISIN: US0068551003). Investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980.
The investigation concerns whether Adeptus Health and certain of its officers and/or directors have violated the federal securities laws.
On March 2, 2017, Adeptus Health revealed that the Company had identified material weaknesses in its internal control over financial reporting related to revenue recognition, accounts receivable, accounting for a contribution to an unconsolidated joint venture, and accounting for equity in earnings of unconsolidated joint ventures. As a result, Adeptus Health is evaluating the effect of these errors in its financial statements for prior periods.
On this news, Adeptus's share price fell $3.76, or 57.40%, to close at $2.79 on March 2, 2017.
The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com
Robert S. Willoughby
SOURCE Pomerantz LLP